Search results
-
Mr Oscar Baldwin
... disease and its rarity. My work aims at understanding the events that allow the normal developing choroid plexus epithelium to transform ...
-
Dr Saif Ahmad
I am a senior clinical oncology trainee currently undertaking a Clinical PhD Fellowship at the MRC Cancer Unit in Prof Ashok Venkitaraman's lab. My research is focused on understanding a novel mechanism by which the BRCA2 tumour suppressor protein...
-
Dr Sujath Abbas
... (OAC), where I investigated the dynamics of mutational events during the development and spread of OAC. Also, along with colleagues I ...
-
Professor Walid Khaled
... works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on ...
-
Dr David Gilligan
David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...
-
Mr David Thurtle
Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer
-
Dr Roisin Owens
Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...
-
Mr Thierry Lefebvre
Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...
-
Professor Andrea Brand
-
Dr Alison Schuldt
-
Mr Arqum Anwar
Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...
-
Dr Annalise Katz-Summercorn
Early detection in oesophageal adenocarcinoma
-
Dr Catherine Lindon
My lab studies cell division in human cells, with particular focus on regulation by ubiquitin-mediated proteolysis. We use time-lapse fluorescence imaging of live cells to measure proteolysis of substrates in real time, and to study the role of...
-
Mr Adam Peryt
-
Mr Andrew Lee
-
Miss Anne Babbage
-
Dr Alan Barnicle
-
Mrs Amanda Walker
-
Dr Adrian Ionescu
I currently work as a post-doctoral research associate at the Cavendish Laboratory, Department of Physics, University of Cambridge, in the Thin Film Magnetism (TFM) group with Prof. Crispin Barnes on an ERC International Training Network project,...
-
Dr Aisling Redmond
Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK...
-
Dr Fazlur Rahman Talukdar
I am spearheading a translational research initiative focused on developing circulating tumour DNA (ctDNA) based biomarkers derived from minimally invasive biospecimens, with the primary objective of early cancer detection and monitoring. I am a...
-
Professor Grant Stewart
Professor Stewart is an academic surgeon at the University of Cambridge, with a focus on developing and promoting surgery related clinical trials and translational research. Grant has a specific interest in optimising management of patients with...
-
Dr Hayley Woffendin
After many years working as a postdoctoral research scientist (Molecular Biologist) within the University and Wellcome Trust Sanger Institute, I have been Scientific Administrator and Graduate Student Administrator with the Department of Oncology Since...
-
Dr Helen Hatcher
Dr Hatcher is the Clinical and Regional lead for young people with cancer specialising in sarcomas and other rare cancers. She qualified in medicine at the University of Cambridge and has trained at the Royal Marsden Hospital in London. Her PhD and post...
-
Dr Hanna Najgebauer
Open Targets Postdoctoral Fellow responsible for the development of new algorithms and computational tools for scoring cancer in vitro models based on their clinical relevance and covered genomic heterogeneity observed in primary disease.
-
Mr Justin Davies
Justin Davies Clinical Director of Digestive Diseases and Consultant Colorectal Surgeon at Addenbrooke's Hospital, and an Associate Lecturer at the University of Cambridge. His thesis was written on molecular stool screening for colorectal cancer, and...
-
Dr Kate Fife
Dr Kate Fife is a consultant clinical oncologist at Addenbrooke's Hospital, Cambridge where she was appointed in 2001. Together with Prof Tim Eisen and Dr Athena Matakidou, she runs a large research focussed renal cancer clinic which is one of the...
-
Dr Myriam Ouberai
I am a Senior Research Associate at the Cambridge Nanoscience Centre where I have undertaken several interdisciplinary projects aiming to decipher the molecular processes involved in Parkinson’s disease or to improve the efficacy and safety of drugs to...
-
Mr James Watson
-
Mrs Sarah Fesco
-
Dr Tony Jackson
... method will have wide application to many problems in the biomolecular sciences. ...
-
Professor Tuomas Knowles
... particular interest in developing microfluidic platforms for biomolecular studies. Much of our work has been focused on protein ...
-
Professor Adrian Liston
... within the tissues. How they migrate there, what controls their numbers and their functions, both immunological and tissue homeostatic in nature. Our ...
-
Professor Andrew Flewitt
... sensors which are capable of edecting mass changes on their surface down to 1 fg in mass. With selective functionalisation of the ...
-
Dr Andrew Bannister
... around with chromatin with a special focus on histones and their modifications. My research has focused on identifying novel histone ...
-
Professor Anna Philpott
... proliferation and differentiation during development, and their application in stem cell and developmental models, will illuminate the ...
-
Dr Anny Wong
... running of the paediatric day unit where children come for their treatment and investigations. She also specialises in the follow-up care of children who have finished their cancer treatment. ...
-
Professor Anthony Davenport
... targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology and in vivo imaging ... to exist from the human genome but recently paired with their cognate transmitters (urotensin II, apelin, ghrelin, neuromedin U, ...
-
Dr Arnaud Comment
... in vivo imaging, aims at differentiating tissues based upon their metabolic and functional activity rather than structural and anatomic ...
-
Dr Alex Cagan
... processes that occur within our bodies as we age and their consequences for health. Evolution is often considered to be an ... dynamics in these species could lead to the discovery of their cancer resistance mechanisms, opening the door for novel therapeutic ...
-
Dr Mariann Bienz
... of this pathway that are potential drug targets, and on their molecular interactions. These include the recently discovered ...
-
Dr Nitzan Rosenfeld
... between tumour changes and ctDNA levels, and their clinical implications. ...
-
Dr Sumru Bayin
... mechanisms that govern neural stem cells not only have implications for facilitating repair but also will allow us to dissect the ...
-
Professor Simon Mendez-Ferrer
... of mesenchymal and haematopoietic stem cells and its implications for bone marrow transplantation procedures and the development of ...
-
Professor Sir David Klenerman
... stages of the oligomerisation of proteins involved in many neurodegenerative diseases. ...
-
Professor Heike Laman
... the recessive mutations in Fbxo7 that give rise to neurodegenerative disease. We use mouse models which have compromised ...
-
Dr Su Metcalfe
... target endogenous neural stem cells in vivo for treatment of neurodegenerative diseases. 2: Application of targeted nanotherapy to control ...
-
Dr Ahsan MEMON
... for driving cell shape changes in physiological and disease conditions. Additionally, Ahsan has designed a device capable of ...
-
Dr Andrew Murray
Our interest lies in the control of mitochondrial respiration and energy metabolism. We are interested in the metabolic response to dietary manipulation and alterations in oxygen supply, including the matching of oxygen demand and supply. We study this...
-
Dr Alasdair Russell
... range of pre-clinical trials to advance our understanding of disease. ...
-
Mr Amit Roshan
... in early melanoma, and progressing our understanding of disease mechanisms in the initiation and progression of localised melanoma. ...
-
Dr Anna Piskorz
... helping in better patient stratification, earlier disease diagnosis, monitoring patient response and improving patient management ...
-
Dr Athena Matakidou
... by developing clinically relevant mouse models of the disease. The lab is employing a number of candidate gene and unbiased ...
-
Dr Chiwen Chang
1. Interaction between NK cells and HLA Class I antigen during immune response. 2. Immunotherapy for cancers and autoimmune diseases.
-
Professor Clemens Kaminski
... study of protein-protein interactions, which are linked to disease, in particular to cancer, Parkinson's disease and Malaria. The techniques are also used for research into molecular ...
